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The antiplasmodial activity and toxicity data of 34 Aloe
species and their main constituents were determined. A
number of the methanol extracts possessed antimalari-
al activity where 50% of the parasite growth was inhibit-
ed (IC50 value) by 32 to 77μg ml
-1 of the extract. The
chemical common to the most active species is the
anthrone C-glucoside homonataloin which inhibited the
chloroquine-resistant Plasmodium falciparum strain
with an IC50 value of 13.46 ± 1.36μg ml
-1. Homonataloin
was a more potent inhibitor of parasite growth than
aloin (IC50 value of 107.20 ± 4.14μg ml
-1). The Aloe
extracts tested did not exhibit any toxicity towards
transformed human kidney epithelium cells at the con-
centrations (0.5–50μg ml-1) used in the antimalarial
assay.
Aloes have been used since antiquity for various phytother-
apeutic purposes. A wide range of cosmetic and therapeutic
benefits have been ascribed to Aloe products derived from
both the gel and the exudate. The most popular medicinal
uses include the wound healing properties of Aloe vera and
the cathartic effect of Aloe anthraquinones. In addition to a
wide range of commercial products derived from aloes,
many species form an integral part of African traditional
healing and scientific evidence is continuously documented
in support of the numerous traditional uses. Aloe-emodin
possesses antiviral activities against poliovirus type 3, her-
pes simplex virus type 1 and 2, varicella-zoster virus,
pseudorabies virus and the influenza virus (Sydiskis et al.
1991, Semple et al. 2001). Antiprotozoal activity of aloe-
emodin against Trypanosoma brucei brucei (IC50 value of 14
μM) has been described (Camacho et al. 2000); while
Agarwal et al. (2000) reported the antifungal properties of
aloe-emodin against Candida albicans, Cryptococcus neo-
formans, Trichophyton mentagrophytes and Aspergillus
fumigatus (MIC range of 25–250μg ml-1). Aloes with antipar-
asitic activity include the aqueous extract of A. barbadensis
against Trichomonas vaginalis (Rojas et al. 1995).
Although aloes are not commonly known to possess anti-
malarial activity, Neuwinger (1996) reports the use of A.
secundiflora and of A. lateritia in Tanzania and Kenya for
treating malaria related symptoms. Brossat et al. (1981)
found A. vaombe to have minimal in vitro antimalarial activi-
ty (82.2 ± 0.7% growth over 78h); whereas in vivo the aque-
ous extract was found to be a non-specific immunostimulant
clearing a P. berghei malaria infection within two days if used
prophylactically before the mice were inoculated. This,
together with the reality of resistant strains of malaria which
continue to emerge and plague the African continent,
encouraged us to further investigate the antiplasmodial
properties of Aloe species, a genus which has gained a rep-
utation as a cure-all group of plants including traditional use
in treating malaria.
Materials and Methods
Plant material (leaves or roots) of 34 species of Aloe, repre-
sentative of the chemotypes defined by Viljoen (1999) were
collected at the National Botanical Institute (Pretoria) and
dried at 28°C for 5 days. The dried leaves were ground and
1g of the powdered material extracted with methanol for
24h. As the primary interest was to assess the activity of the
polar anthrone and chromone glycosides contained in the
leaf exudate only methanol extracts were prepared. After fil-
tration the methanol was evaporated and all samples recon-
stituted in DMSO to the desired initial concentration.
Samples were dissolved in methanol and passed through
Phenomenex C18 cartridges. These purified samples were
dissolved in methanol-water (1:1) and injected into the
HPLC system. Operating conditions were as follows: A
Phenomenex IB-Sil column was used (C18 reverse phase,
5μm particle size, 250mm x 4.6mm internal diameter; flow
rate 1ml min-1; 20 Fl sample loop). The solvent system com-
prised a 30% to 60% linear gradient of methanol in water
over 25min, 3min isocratic, 100% in 2min, 4min isocratic.
Detection was by diode array detector, using two channels
(A set at 275 ± 70nm; B set at 365 ± 40nm). Compounds
were tentatively identified by comparison of the retention
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times and UV/VIS spectra with reference samples. Authentic
reference samples were made available through previous
studies (Viljoen 1999).
The chloroquine-resistant Gambian FCR-3 strain was cul-
tured in vitro according to the method described by Jensen
and Trager (1976). Briefly, parasitised erythrocytes were
suspended at a 5% haematocrit in RPMI-1640, supplement-
ed with 10mM D-glucose, 0.32mM hypoxanthine, 50mg l-1
gentamicin, 10% (v/v) heat inactivated human plasma and
was buffered with 25mM HEPES and 25mM NaHCO3.
Cultures were maintained at 37°C with a gas mixture of 5%
CO2, 3% O2 and the balance with N2. Cultures were syn-
chronised with 5% D-sorbitol when the parasites were in the
ring stage (Lambros and Vanderberg 1979). The percentage
parasitaemia and stages were assessed daily by microscop-
ic examination of thin blood smears stained with Giemsa.
The antimalarial activity of the various Aloe extracts was
determined using the tritiated hypoxanthine incorporation
assay (Desjardins et al. 1972). The parasite suspension,
consisting of predominately the ring stage, was adjusted to
a 0.5% parasitaemia and 1% haematocrit and exposed to
the various concentrations of Aloe extracts for a single (48h)
and double (78h) cycle of parasite growth. All assays were
carried out using untreated parasites and uninfected red
blood cells as controls. Labelled 3H-hypoxanthine (0.5μCi/
well) was added after 24h and the cells were harvested at
the appropriate time on a GFB-filtermat with a Titertek® cell
harvester. The filtermats were dried, transferred to sample
bags which were filled with scintillation cocktail and sealed.
The concentration that inhibits 50% of parasite growth (IC50
value) was determined from the sigmoid dose response
curve generated by the Enzfitter® and Prism® software.
Chloroquine and quinine were used as the reference anti-
malarial agents.
For the toxicity assays Graham cells (transformed human
kidney epithelium cells) and GCT (giant cell tumour) lung
cancer cells were maintained continuously in culture at 37°C
in 5% CO2. The MTT (3-[4,5-dimethylthiazol-2yl]-
2,5diphenyltetrazolium bromide) cellular viability assay was
used to determine the toxicity profile of the extracts
(Mossmann 1993). The trypsinised cell suspension was
adjusted to 0.5 million cells ml-1 and plated out with the Aloe
extracts. The extracts were tested at the same concentra-
tions used in the antimalarial assay. After 44h of incubation,
2mM MTT was added to the plates and incubated for a fur-
ther 4h. DMSO was added to stop the reaction and to dis-
solve the formazan crystals. The absorbance was read at
the test wavelength of 540nm and reference wavelength of
690nm and the percentage cellular viability calculated with
appropriate controls taken into account.
Results and Discussion
The 34 Aloe species tested showed variable antimalarial
activity. Aloe excelsa, A. bulbilifera, A. ramosissma, A.
arborescens, A. kedongensis and A. esculenta showed min-
imal inhibitory activity (10–20%) over a double cycle (78h) of
parasite growth. Aloe andongensis, A. microstigma, A. mitri-
formis, A. verdoorniae, A. spicata, A. suzannae, A morijen-
sis and A. tidmarshii were slightly more active by inhibiting
approximately 40% of parasite growth over the double cycle.
These species are chemically diverse and no obvious corre-
lation could be found between the recorded activity (or lack
thereof). The chemical profiles are summarised in Table 1.
Aloe microstigma produces a suite of anthrone derivatives
(Viljoen and Van Wyk 2001) while Aloe mitriformis accumu-
lates two cinnamoyl chromones as the major metabolites
(Viljoen and Van Wyk 1999). These two species also differ
markedly in chemical composition when compared to the
flavonoid-producing Aloe suzanne (Viljoen et al. 1998), the
plicatolside-producing A. morijensis (Viljoen et al. 1999) and
the aloin-accumulating A. spicata (Viljoen and Van Wyk
2001).
The leaf extracts of Aloe viridiflora, A. wickensii, A. spe-
ciosa and A. suprafoliata exhibited the most promising anti-
malarial activity over a single and double cycle of growth
(Table 1), with A. viridiflora being the most active (Figure 1).
HPLC analysis of these species (Figure 2) indicates the
presence of the anthrone C-glucoside homonataloin A and B
to be present in all four species. It is interesting to note that
A. mitriformis also contains homonataloin but in much lower
quantities (20%) compared to the ca. 50–60% homonataloin
recorded for the four most active species.
As most species of Aloe produce either aloin or homonat-
aloin as the major anthrone C-glycoside (Viljoen 1999), the
activity of these two compounds were tested. Pure homona-
taloin was found to be approximately 8 times more active
than the aloin standard over a single and double cycle of
parasite growth in both chloroquine-resistant and -sensitive
malaria parasites (Table 2). The chloroquine-sensitive 3D7
strain was more resistant to the extracts than the chloro-
quine-resistant FCR-3 strain with IC50 values for aloin of
169.76 ± 11.5μg ml-1 and 109.05 ± 2.21μg ml-1 over a single
and double cycle of growth, respectively. IC50 values
obtained for homonataloin were 18.24 ± 1.16μg ml-1 and
15.43 ± 0.47μg ml-1 over a single and double cycle of growth,
respectively.
The genus Aloe is characterised by a strong distinction
Figure 1: The sigmoid dose response curve showing the antimalari-
al activity of Aloe viridiflora on the in vitro growth of Plasmodium fal-
ciparum over a single () and double () cycle of parasite growth
log [Aloe viridiflora] (μg.ml-1)
%
 P
a
ra
s
it
e
 g
ro
w
th
Van Zyl and Viljoen108
Table 1: Anti-plasmodial activity and leaf exudate chemistry of Aloe species. 1 = aloesin, 2 = 7-hydroxyaloesin, 3 = aloenin, 4 = homonat-
aloside B, 5 = 10-hydroxyaloin B, 6 = 8-O-methyl-7-hydroxyaloin, 7 = 3'-O-coumaroylaloesin, 8 = aloeresin A, 9 = plicataloside, 10 = microstig-
min, 11 = aloeresin E, 12 = isovitexin, 13 = 5-hydroxyaloin B, 14 = broomii chromone I, 15 = 10-hydroxyaloin-6'-monoacetate, 16 = aloeresin
D, 17 = aloeresin F, 18 = aloin A & B, 19 = 6-O-coumaroylaloesin, 20 = homonataloin A & B, 21 = deacetyllittoraloin, 22 = aloinoside A & B,
23 = littoraloin, 24 = microdontin A & B, 25 = flavanones, 26 = nataloin A & B, 27 = broomii chromone II, 28 = 3'6'-di-O-coumaroylaloesin
Species % Parasite growth at 50μg ml-1 Exudate chemistry
Single cycle Double cycle
% s.d.1 n % s.d. n
A. andongensis2 87.13 3.95 5 67.17 17.09 6
A. arborescens 90.27 11.86 2 81.27 0.07 2 1,3, 16, 18
A. barberae2 90.78 11.99 2 78.40 6.87 2
A. boylei 87.74 23.21 4 70.60 23.78 4 12
A. broomii 97.29 1.58 2 72.93 6.53 2 1, 14, 13, 18, 10, 7
A. bulbilifera2 96.30 10.73 3 90.78 2.67 2
A. capitata var. gneissicola 96.09 0.89 2 79.24 0.88 2 1, 2, 18
A. castanea 93.52 0.08 2 70.20 2.67 2 1, 18, 19
A. commixta 102.04 23.79 2 91.33 10.19 2 1, 12, 18
A. deyeri2 92.33 12.18 2 77.52 2.92 2
A. dichotoma2 92.34 3.85 3 72.35 18.08 3
A. divaricata2 93.72 12.45 3 80.77 15.58 2 2, 18
A. esculenta 91.98 7.66 3 80.65 13.78 3 2, 5, 15, 18, 21, 23
A. excelsa 96.27 8.32 3 90.23 13.46 2 1, 2, 8, 16, 18
A. globuligemma2 83.26 11.90 4 73.75 10.51 3 1, 2, 16
A. juvenna2 89.46 6.99 2 76.08 9.45 2
A. karasbergensis2 101.49 10.37 2 75.10 12.08 2
A. kedongensis2 91.40 6.23 2 79.69 1.03 2 1, 2, 3, 26
A. marlothii (leaves) 92.28 10.63 2 81.81 6.37 2 1, 8, 16, 18
A. marlothii (roots) 81.37 15.80 4 64.26 9.19 3 Van Wyk et al. (1995)
A. microstigma2 86.54 8.78 6 66.17 8.66 6 1, 2, 10, 13
A. mitriformis 84.57 8.61 3 61.07 14.62 4 1, 8, 11, 17, 20
A. morijensis 82.86 2.69 2 69.51 6.17 2 9
A. ramosissima2 88.92 19.71 2 85.36 2.06 2
A. secundiflora2 90.28 1.64 2 65.97 1.85 2 3, 16, 18
A. spicata2 92.18 7.42 3 63.95 11.50 3 1, 18, 19
A. speciosa2 64.24 7.59 4 44.81 14.69 5 20
A. succotrina2 100.66 5.73 2 78.83 3.42 2 1, 22
A. suprafoliata 65.19 14.95 4 50.46 17.79 4 1, 8, 20
A. suzannae 96.00 1.34 2 68.50 17.18 3 12, 25
A. tidmarshii2 90.22 5.18 2 68.82 4.19 2 12
A. vaombe2 90.81 18.74 2 82.18 0.70 2 6
A. verdoorniae2 85.24 14.67 3 63.73 6.46 3
A. viridiflora 16.71 4.18 4 9.83 4.46 5 1, 8, 20
A. wickensii 49.67 12.00 5 45.06 16.64 5 1, 4, 7, 20
1 s.d. = standard deviation
2 Species contain in addition to compounds 1–28 various compounds which have not been identified and only have a restricted occurrence in Aloe
Table 2: The antimalarial activity and toxic effects of the Aloe extracts in comparison to the reference antimalarial agents, chloroquine and
quinine
Aloe extract Antimalarial activity IC50 value (μg ml-1) % Cellular viability at 50μg ml-1
Single cycle Double cycle Graham cell line GCT cell line
A. viridiflora 31.71 ± 5.10 21.83 ± 5.71 100.07 ± 15.18 121.20 ± 4.37
A. wickensii 55.06 ± 10.34 44.9 ± 9.64 90.24 ± 3.75 99.65 ± 6.28
A. speciosa 76.76 ± 15.89 45.00 ± 18.06 94.65 ± 19.35 109.41 ± 2.16
A. suprafoliata 70.45 ± 18.93 54.74 ± 19.05 88.43 ± 12.95 119.15 ± 5.06
A. marlothii (roots) >50 55.74 ± 22.66 91.14 ± 8.87 106.12 ± 1.58
Aloin 107.20 ± 4.14 57.14 ± 5.65 98.39 ± 3.57 n.d.
Homonataloin 13.46 ± 1.36 9.22 ± 3.07 100.00 ± 3.57 n.d.
Chloroquine 0.09 ± 0.02 0.01 ± 0.01 98.00 ± 2.86 n.d.
Quinine 0.13 ± 0.04 0.03 ± 0.01 91.07 ± 4.67 n.d.
n.d. = not determined
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between subterranean and above ground metabolism
(Dagne et al. 2000). For this reason we also included the
root extract of A. marlothii which possessed some inhibitory
activity which was more pronounced over a double cycle of
growth (Table 1). In comparison to the 42.3% inhibitory activ-
ity of 50μg ml-1 of the root extract, the leaf extract only inhib-
ited 18.2% parasite growth over a double cycle of growth.
The roots of Aloe species generally accumulate
anthraquinones, preanthraquinones and bianthraquinoids
(Wyk et al. 1995, Dagne et al. 2000). It is interesting to note
that we recently found emodin (an anthraquinoine) to inhibit
the in vitro intra-erythrocytic growth of chloroquine-resistant
FCR-3 malaria (S Belotti, pers. comm.).
Aloes are store houses of numerous medicinal com-
pounds and it is noteworthy to report the antimalarial prop-
erties in a screening of 7% (34 out of 460 species) of this
genus characterised by immense chemical complexity.
Furthermore, it is encouraging that the species which exhib-
ited inhibitory effects on the intra-erythrocytic growth of the
malaria parasite are not toxic to human cell lines as pre-
sented in Table 2. Considering that natural molecules such
as quinine and artemisinin have acted as natural templates
in the development of antimalarial agents, we wish to
encourage further investigations into Aloe constituents in
search for potent antiplasmodial agents.
Acknowledgements — We thank the National Botanical Institute
(Pretoria) for access to the Aloe collection and supplying us with
plant material, Mrs C van Zyl for technical assistance, the University
of the Witwatersrand Medical Faculty Research Endowment Fund,
the University Research Committee and the National Research
Foundation for financial support.
References
Agarwal SK, Singh SS, Verma S, Kumar S (2000) Antifungal activi-
ty of anthraquinone derivatives from Rheum emodi. Journal of
Ethnopharmacology 72: 43–46
Brossat JY, Leduaut JY, Ralamboranto L, Rakotovao LH, Solar S,
Gueguen A, Coulanges P (1981) Immunostimulating properties of
an extract isolated from Aloe vahombe. 2. Protection in mice by
fraction F1 against infections by Listeria monocytogenes, Yersinia
pestis, Candida albicans and Plasmodium berghei. Archives de
L’Institut Pasteur de Madagascar 48: 11–34
Camacho MR, Kirby GC, Warhurst DC, Croft SL, Phillipson JD
(2000) Oxoaporphine alkaloids and quinones from Stephania din-
klagei and evaluation of their antiprotozoal activities. Planta
Medica 66: 478–480
Dagne E, Bisrat D, Viljoen AM, Van Wyk B-E (2000) The chemistry
of Aloe species — A review. Current Organic Chemistry 4:
1055–1078
Desjardins RE, Carfield CJ, Haynes DJ, Chulay JD (1972)
Quantitative assessment of antimalarial activity in vitro by semi-
automated microdilution technique. Antimicrobial Agents and
Chemotherapy 16: 710–718
Figure 2: The HPLC chromatograms for the most active species showing the presence of the anthrone C-glucoside homonataloin common
to Aloe viridiflora, A. wickensii, A. speciosa and A. suprafoliata. Peak numbers correspond to compounds in Table 1
Van Zyl and Viljoen110
Jensen JB, Trager W (1976) Human malaria parasites in continuous
culture. Science 193: 674–675
Lambros C, Vanderberg P (1979) Synchronisation of Plasmodium
falciparum erythrocytic stages in culture. Journal of
Parasitology 65: 418–420
Mossmann T (1993) Rapid colorimetric assay for cellular growth
and survival: application to proliferation and cytotoxicity assays.
Journal of Immunological Methods 1993, 65: 55–63
Neuwinger HD (1996) African Ethnobotany. Poisons and Drugs.
Chapman & Hall, London, UK, pp 3–9
Rojas L, Matamoros M, Garrido N, Finlay C (1995) The action of an
aqueous extract of Aloe barbadensis Miller in an in-vitro culture of
Trichomonas vaginalis. Revista Cubana de Medicinia Tropical
47: 181–184
Semple SJ, Pyke SM, Reynolds GD, Flower RL (2001) In vitro
antiviral activity of the anthraquinone chrysophanic acid against
poliovirus. Antiviral Research 49: 169–178
Sydiskis RJ, Owen DG, Lohr JL, Rosler KH, Blomster RN (1991)
Inactivation of enveloped viruses by anthraquinones extracted
from plants. Antimicrobial Agents and Chemotherapy 35:
2463–2466
Van Wyk B-E, Yenesew A, Dagne E (1995) Chemotaxonomic sur-
vey of anthraquinones and pre-anthraquinones in roots of Aloe
species. Biochemical Systematics and Ecology 23: 267–275
Viljoen AM (1999) A chemotaxonomic study of phenolic leaf com-
pounds in the genus Aloe. PhD thesis, Rand Afrikaans University,
Johannesburg, South Africa
Viljoen AM, Van Wyk B-E (1999) The chemotaxonomic value of two
cinnamoyl chromones, aloeresin E and F in Aloe (Aloaceae).
Taxon 48: 747–754
Viljoen AM, Van Wyk B-E (2001) A chemotaxonomic and morpho-
logical appraisal of Aloe series Purpurascentes, Aloe section
Anguialoe and their hybrid, Aloe broomii. Biochemical
Systematics and Ecology 29: 621–632
Viljoen AM, Van Wyk B-E, Newton LE (1999) Plicataloside in Aloe
— a chemotaxonomic appraisal. Biochemical Systematics and
Ecology 27: 507–517
Viljoen AM, Van Wyk B-E, Van Heerden FR (1998) The distribution
and chemotaxonomic significance of flavonoids in the genus
Aloe. Plant Systematics and Evolution 211: 31–42
Edited by AK Jäger
